1,688
Participants
Start Date
September 27, 2022
Primary Completion Date
March 31, 2023
Study Completion Date
No treatment given
Novo Nordisk Investigational Site, Puteaux
Lead Sponsor
Novo Nordisk A/S
INDUSTRY